The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies. (2024)
Attributed to:
Vaccinology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2024.1325387
PubMed Identifier: 38469296
Publication URI: http://europepmc.org/abstract/MED/38469296
Type: Journal Article/Review
Volume: 15
Parent Publication: Frontiers in immunology
ISSN: 1664-3224